Concurrent use of multiple chemotherapy resistance modulators with etoposide in patients with resistant malignancies

International Journal of Oncology

Volumn 11, Issue 4, 1997, Pages 709-716

  Stewart, David J ^a,b   Goel, Rakesh ^a,b   Christine Cripps, M ^a,b   Yau, Jonathan ^a,b   Huan, Susan ^a,b   Tomiak, Eva ^a,b   Davies, Ross A ^b   Dulude, Hélène ^c   Gallant, Gilles ^c  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

Chemotherapy; Cyclosporin; Dipyridamole; Etoposide; Ketoconazole; Metronidazole; Resistance modulators; Tamoxifen

Indexed keywords

DIPYRIDAMOLE; ETOPOSIDE; KETOCONAZOLE; METRONIDAZOLE; TAMOXIFEN;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DRUG EFFICACY; DRUG MIXTURE; DRUG POTENTIATION; FEMALE; HUMAN; KIDNEY CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; MULTIDRUG RESISTANCE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SOLID TUMOR; TREATMENT PLANNING;

EID: 0030932009     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.11.4.709     Document Type: Article

References (15)

1. Zijlstra JG, De Vries EGE and Mulder NHL: Multifactorial drug resistance in adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res 47: 1780-1784, 1987.
2. Volm M, Kastel M, Mattern J and Efferth T: Expression of resistance factors (p-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas. Cancer 71: 3981-3987, 1993.
3. Raaphorst GP, Yang DP, Grewaal D, Stewart D, Goel R and Ng CE: Analysis of mechanisms of cisplatin resistance in three pairs of human tumour cell lines expressing normal and resistant responses to cisplatin. Oncol Rep 2: 1037-1043, 1995.
4. Brock I, Hipfner DR, Nielsen BS, Jensen PB, Deeley RG, Cole SP and Sehested M: Sequential coexpression of the multidrug resistance genes MRP and mdr1 and their products in VP-16 (etoposide)-selected H69 small cell lung cancer cells. Cancer Res 55: 459-462, 1995.
5. Harker WG and Sikic BI: Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell lines MES-SA. Cancer Res 45: 4091-4096, 1985.
6. Ishida Y, Ohtsu T, Hamada H, Sugimoto Y, Tobinai K, Minato K, Tsuruo T and Shimoyama M: Multidrug resistance in cultured human leukemia and lymphoma cell lines detected by a monoclonal antibody, MRK16. Jpn J Cancer Res 80: 1006-1013, 1989.
7. Tebbi CK, Chervinsky D and Baker RM: Modulation of drug resistance in homoharringtonine-resistant C-1300 neuroblastoma cells with cyclosporin A and dipyridamole. J Cell Physiol 148: 464-471, 1991.
8. Mans DR, Schuurhuis GJ, Treskes M, Lafleur MV, Retel J, Pinedo HM and Lankelma J: Modulation by D, L-buthionine-S, R-sulphoximine of etoposide cytotoxicity on human non-small cell lung, ovarian and breast carcinoma cell lines. Eur J Cancer 28A: 1447-1452, 1992.
9. Mirski SE, Evans CD, Almquist KG, Slovak ML and Cole SP: Altered topoisomerase II alpha in a drug-resistant small cell lung cancer cell line selected in VP-16. Cancer Res 53: 4866-4873, 1993.
10. Stewart DJ and Evans WK: Non-chemotherapeutic agents potentiate chemotherapy efficacy. Cancer Treatment Rev 16: 1-40, 1989.
11. Leyland-Jones B, Dalton W, Fisher GA and Sikic B: Reversal of multidrug resistance to cancer chemotherapy. Cancer 72: 3484-3488, 1993.
12. Goodman GE, Yen YP, Cox TC and Crowley J: Effect of verapamil on in vitro cytotoxicity of adriamycin and vinblastine in human tumor cells. Cancer Res 47: 2295-2304, 1987.
13. Akiyama S, Shiraishi N, Kuratomi Y, Nakagawa M and Kuwano M: Circumvention of multi-drug resistance in human cancer cells by thioridazine, trifluoperazine, and chlorpromazine. J Natl Cancer Inst 76: 839-844, 1986.
14. Tsuruo T, Iida H, Kitatani Y, Yokota K, Tsukagoshi S and Sakurai Y: Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells. Cancer Res 44: 4303-4307, 1984.
15. Twentyman PR, Fox NE and White DJG: Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell line. Br J Cancer 56: 55-57, 1987.